Medexus Pharmaceuticals (MDP) Competitors

Medexus Pharmaceuticals (TSE:MDP) and Organigram (TSE:OGI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

Does the media prefer MDP or OGI?

In the previous week, Organigram had 1 more articles in the media than Medexus Pharmaceuticals. MarketBeat recorded 1 mentions for Organigram and 0 mentions for Medexus Pharmaceuticals. Medexus Pharmaceuticals' average media sentiment score of 0.00 equaled Organigram'saverage media sentiment score.

Company	Overall Sentiment
Medexus Pharmaceuticals	Neutral
Organigram	Neutral

Is MDP or OGI more profitable?

Medexus Pharmaceuticals has a net margin of 3.25% compared to Organigram's net margin of -31.69%. Medexus Pharmaceuticals' return on equity of 11.07% beat Organigram's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medexus Pharmaceuticals	3.25%	11.07%	4.89%
Organigram	-31.69%	-17.59%	-5.56%

Do analysts recommend MDP or OGI?

Medexus Pharmaceuticals presently has a consensus price target of C$4.57, indicating a potential upside of 64.86%. Organigram has a consensus price target of C$3.33, indicating a potential upside of 25.00%. Given Medexus Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe Medexus Pharmaceuticals is more favorable than Organigram.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medexus Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	4 Strong Buy rating(s)	3.29
Organigram	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders have more ownership in MDP or OGI?

0.8% of Medexus Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.2% of Organigram shares are owned by institutional investors. 9.1% of Medexus Pharmaceuticals shares are owned by insiders. Comparatively, 31.3% of Organigram shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has higher earnings and valuation, MDP or OGI?

Medexus Pharmaceuticals has higher earnings, but lower revenue than Organigram. Medexus Pharmaceuticals is trading at a lower price-to-earnings ratio than Organigram, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medexus Pharmaceuticals	C$105.66M	0.85	C$3.26M	C$0.02	138.50
Organigram	C$223.82M	1.59	-C$57.23M	C$0.01	221.67

Which has more volatility and risk, MDP or OGI?

Medexus Pharmaceuticals has a beta of 1.598909, meaning that its stock price is 60% more volatile than the S&P 500. Comparatively, Organigram has a beta of 2.185402, meaning that its stock price is 119% more volatile than the S&P 500.

Summary

Medexus Pharmaceuticals beats Organigram on 8 of the 15 factors compared between the two stocks.